News & views
Our collective understanding of mental health is increasing all the time, with advances in neuroscience, psychotherapy, psychopharmacology and digital platforms.
We are developing psilocybin therapy to help people who have mental health challenges, including treatment-resistant depression.
The cost of developing psilocybin therapy, with clinical trials in multiple countries, is significant, and involves considerable risk and resource. We think it’s an investment worth making. We are also committed to investing in other innovative treatments to address the rapidly growing problem of mental health conditions.
Psilocybin therapy is unusual because it’s an innovative protocol that combines a medicine with psychological support.
Here we explain our full commitment to Open Science, including publishing the results from all our trials and supporting the publication of all results from independent studies that use our psilocybin.
January 07, 2020How do we train our therapists and do we require them to have personal experience with psilocybin?
Our therapist training programme has been designed by a group of some of the most experienced psychedelic therapists in the world.